Dermatology Times: June 15, 2025
Across
- 8. Emotional condition linked to chronic urticaria
- 9. Conference where bimekizumab 3-year data was presented
- 10. Company pioneering WHO-5 Index use in dermatology trials
- 12. Infrared and visible light contribute to this pigmentation concern
- 15. Antibody showcased for CSU symptom reduction
- 17. Autoimmune skin disease featured in Dr Friedman’s psychosocial care discussion
Down
- 1. Clinical term for persistent hives
- 2. Drug from the JADE REAL study for moderate to severe AD
- 3. Type of facial massage tool evaluated in clinical study
- 4. Drug in early-stage trial for cold urticaria
- 5. IL-31 inhibitor noted for itch relief in AD
- 6. Drug that inhibits joint structural damage in PsA
- 7. Digital wellness tool launched by Hydrafacial
- 11. Abbreviation for condition marked by widespread pustules
- 13. Plant-derived innovation in regenerative skin care
- 14. Abbreviation for inflammatory skin disease targeted at RAD 2025
- 16. Ingredient paired with Cuticapil in hair loss treatment